ROUTINELY AVAILABLE NONINVASIVE TESTS DISCRIMINATE ADVANCED FIBROSIS DUE TO NASH IN THE PHASE 3 STELLAR TRIALS OF THE ASK1 INHIBITOR SELONSERTIB Article

Full Text via DOI: 10.1136/gutjnl-2019-IDDFabstracts.267 Web of Science: 000472085300264
Industry Collaboration International Collaboration

Cited authors

  • Wong, Vincent Wai-Sun; Anstee, Quentin; Lawitz, Eric; Alkhouri, Naim; Romero-Gomez, Manuel; Okanoue, Takeshi; Trauner, Michael; Kersey, Kathryn; Li, Georgia; Subramanian, Mani; Myers, Robert; Djedjos, Stephen; Han, Ling; Tuan Nguyen; Kohli, Anita; Bzowej, Natalie; Younes, Ziad; Sarin, Shiv; Shiffman, Mitchell; Harrison, Stephen; Goodman, Zachary; Younossi, Zobair

Authors

Publication date

  • 2019

Published in

  • Gut  Journal

Category

International Standard Serial Number (ISSN)

  • 0017-5749

Start page

  • A136

End page

  • A137

Volume

  • 68